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Abstract 
 
Mechanisms of immunity, and of the host-pathogen interactions in general are among the 
most fundamental problems of medicine, ecology, and evolution studies. Here, we 
present a microscopic, protein-level, sequence-based model of immune system, with 
explicitly defined interactions between host and pathogen proteins. Simulations of this 
model show that possible outcomes of the infection (extinction of cells, survival with 
complete elimination of viruses, or chronic infection with continuous coexistence of cells 
and viruses) crucially depend on mutation rates of the viral and Immunoglobulin proteins.  
Infection is always lethal if the virus mutation rate exceeds a certain threshold. Potent 
Immunoglobulins are discovered in this model via clonal selection and affinity 
maturation. Surviving cells acquire lasting immunity against subsequent infection by the 
same virus strain. As a second line of defense cells develop apoptosis-like behavior by 
reducing their lifetimes to eliminate viruses. These results demonstrate the feasibility of 
microscopic sequence-based models of immune system, where population dynamics of 
the evolving B-cells is explicitly tied to the molecular properties of their proteins. 
 
 
 
 
 
Introduction 
 
One of the most fascinating aspects of adaptive immunity is that it represents 
Darwinian evolution in action.   Selection of the most fit B-cells expressing potent 
Immunoglobulins occurs through clonal selection and affinity maturation – processes that 
exemplify classic features of evolutionary selection (1-3). Enormous and fruitful 
experimental effort has been devoted to study specific mechanisms responsible for 
immune response, and the emerging detailed molecular picture confirmed earlier Burnet’s 
hypothesis that some specificity for diverse antigens exists before these antigens are 
encountered (3, 4). A detailed micoscopic picture of maturation of affinity in  immune 
response is emerging (5, 6).  
Theoretical studies of immunity have been extensive and included analyses from 
population dynamics perspective (7) and in silico modeling of synapse formation and 
other molecular aspects of immune response (8). Phenomenological models of immune 
response have been reviewed in (9). Kamp and Bornholdt (10),  Brumer and Shakhnovich 
(11) and Wang and Deem (3) considered the problem of co-evolution of host immune 
system (B-cells) and parasite (virus) in the quasispecies paradigm, assuming the existence 
of a master genome for both host and virus. Population dynamics approaches to study 
immunity have been successful in identifying global aspects of epidemics as well as 
optimal treatment strategies. A drawback of these approaches is in their 
phenomenological nature, which omits many microscopic details of the interaction 
between the host and parasite 
Generally, a detailed mechanistic understanding of evolutionary processes is 
limited by lack of clear picture of genotype-phenotype relationship. In this regard 
immunity represents an important exception where direct relationship between antibody 
potency (a genotypic trait) and B-cell activation to proliferate (a phenotypic trait) has 
been found  (3). Recently we developed  a model that combines microscopic, sequence-
based, description of dynamics of genes and stability of encoded proteins with cell 
population dynamics governed by exact relationship between genotype and phenotype 
(12). This model was applied in  (12) to study early evolution of Protein Universe. Here 
we extend this line of modeling to study fundamental principles of immunity. We 
explicitly model interactions between viral and host defense (Immunoglobulin-like) 
proteins and assume that the strength of interaction between viral and host proteins 
affects the replication rate of both host cells and viruses, and therefore governs their 
population dynamics. In our model viruses infect Ig-producing cells, i.e. attack the 
immune system directly. As such this model is most directly applicable to class of 
infections that target immune system such as HIV or Epstein-Barr virus. We build the 
model bottom up based on simplest ‘’common-sense’’ mechanistic assumptions and 
sequence-based molecular description of relevant proteins and their interactions. 
Specifically we make the following three mechanistic microscopic assumptions. First, we 
assume that stronger binding between immunoglobulin (Ig) proteins and viral antigens 
inhibits replication of viruses within the host cells (i.e. decreases viral replication rate). 
Second, to account for B-cell activation mechanism, we assume that the rate of B-cell 
division increases upon stronger binding between viral proteins and Ig-proteins. Finally 
we assume that the rate of B-cell division drops if Immunoglobulin proteins bind cell’s 
own proteins, modeling the effect of autoimmunity.  As mutations accumulate in both 
Immunoglobulins and viral proteins, selection pressure appears to optimize the Ig 
sequences for the strongest possible binding to the viral ones, whereas evolving viral 
sequences try to decrease the binding energy. This competition unfolds in the presence of 
the protein stability constraints, which limit the accessible repertoire of sequences. 
Indeed, strong binding between two sequences normally requires a hydrophobic patch on 
their surfaces; however, a hydrophobic surface may be unfavorable with respect to the 
folding free energy, normally decreasing protein stability (13).  
Dynamics of the system establishes the qualitative outcome of an infection in this 
model: healing (survival of host cells with complete elimination of viruses), extinction of 
host cells, or development of a chronic infection, where the cells and viruses coexist, and 
the fraction of infected cells remains constant with time. Qualitatively, one can expect 
that for a very slowly mutating virus, cells will evolve a strongly virus-binding Ig protein, 
suppress virus replication within the infected cells, and eliminate the virus population. On 
the other hand, the speed at which such immunity evolves is fundamentally limited by the 
mutation rate of the Ig-like protein, and by the speed at which the favorable sequences 
spread through the population. Therefore, if the mutation rate of viruses is high enough, 
their sequence change can outpace the evolution of cellular response, resulting in a robust 
lethal infection.  
. Below, we will present the results of simulations for this ab initio, microscopic 
model of immune response, and show that physics-based, sequence-level simulations can 
provide crucial insights, on all scales, into the development and dynamical regimes of 
immune response. 
 
Model 
 In the model (see  Supplementary Information for more details), each independent 
host cell carries one Ig-like protein and three other functional proteins. Proteins are 
modeled as 27-unit compact polymers, (14) so their thermodynamic properties, stability 
and interaction can be calculated exactly from their primary sequences (12, 14). Each 
virus carries one protein; once a virus infects a cell, the virus starts to replicate at a rate, 
bv, dependent on the stability of viral protein and the interaction strength between viral 
and Ig proteins. 
  
 ( )),(1)( int0 vIgPvPbb natvv −⋅⋅= , (1) 
 
where b0v is a viral replication rate constant, Pnat(v) is protein stability of virus (i.e. 
Boltzmann probability for the virus protein to be in its native conformation), and Pint(Ig,v)  
is Boltzmann probability of a specific interaction between Ig protein and virus protein 
which serves as a measure of their interaction strength (see Supplementary Text for exact 
definition of this quantity) . Strong binding inhibits virus replication. Once the number of 
viruses in a given cell exceeds the lysis threshold, the viruses kill their hosts, are released, 
and can infect uninfected cells. If free viral particles cannot find any host cell, they are 
removed. The replication rate of the cells b is determined by interaction between Ig and 
viral proteins if the cell is infected (strong binding increases cell replication rate), and the 
autoimmunity effect (strong binding between Ig and a functional protein decreases the 
replication rate),  
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where Pint(Ig,gi) and Pint(Ig,vj) are respectively the Ig protein’s interaction strength  with 
i-th normal functional protein of the cell and j-th viral particle in the cell, and indices i 
and j run from 1 to 3 and the number of viruses in the cell respectively. In the context of 
the immune system, an increase of cell replication rate with the antigen binding strength 
is the well-known phenomenon of B-cell activation by an antigen (15-17) . Interestingly, 
the dependence of cell replication rate on the interaction strength is crucial for the 
development of strong immune response that results in complete elimination of the 
infection; without it strong immune response does not develop: all simulation runs 
converged to the chronic infection outcome (see Supplementary Information). 
Upon division of an infected cell, viruses are randomly distributed between its 
two off-springs, and when an infected cell dies, any viruses it contains are also removed 
from the population. The simulation ensemble consists of up to 5000 completely 
independent cells and 20000 independent virus particles, mutating and replicating 
according to the above rules. If necessary, cell population is clipped at 5000, simulating a 
chemostat. The mutation rate of Ig proteins is set significantly above that of functional 
proteins, mimicking somatic hypermutation found in B-cells (18, 19), and the mutation 
rate of viruses is also higher than the normal host protein mutation rate. For the initial 
1500 evolutionary time steps, cells are allowed to evolve with mutation rate m=0.005 per 
protein per time step to equilibrate their protein sequences, and then mutation rate drops 
to m=0.0005 (see Supplementary Information for details). At t=2001, one thousand of 
identical free viruses are introduced randomly into the system, starting the infection.  In 
order to evaluate how mutation rates of Ig genes and viruses affect the outcome of cell-
virus competition, we run multiple simulations with different mutation rates of viruses 
and Ig genes while keeping mutation rates of cell’s genes fixed as described above. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results and discussion 
 Extensive simulations of the model over a broad range of parameters (B-cell and 
virus replication rates, and mutation rates of Ig and viruses) showed that the outcome of 
an individual simulation run falls into one of the three categories: healing, with complete 
extinction of the virus; extinction of the host (and the ensuing extinction of the virus); and 
chronic infection, where viruses and cells coexist with neither species winning the 
competition. The probability of each of the three outcomes depends on the parameters of     
 
 
 
 
 
 
Figure 1. Emergence of immunity. (A) Population of cells as a function of time in 
representative simulation runs resulting in healing (H), extinction (E) or chronic 
infection (C). Infection occurs at t=2001. (B) Population of viruses in the same 
simulation runs. (C) Averaged (over all Ig proteins and viruses) strength of interaction 
Pint between viral and Ig proteins shows that strongly binding Ig’s gain selective 
advantage, rapidly increasing Pint as the cells try to overcome infection. (D) Phase 
diagram showing the probability of cell survival in 200 runs (color scale) as function of 
the mutation rates of Ig and viral proteins (relative to the mutation rates of functional 
proteins in the cell). 
 
the model, most notably on mutation rates of Ig and virus genes. Figures 1A and 1B 
present the population dynamics of cells and viruses, respectively, for representative  
simulation runs corresponding to the healing (H), chronic infection (C), and extinction 
(E) cases. One can see that in all cases, infection is followed by an incubation period 
during which the cell population remains constant, and the virus population increases  
until lysis threshold is achieved in the majority of cells. Ensuing lysis causes an abrupt 
drop of the cell population (Figure 1A). Duration of the incubation period depends on the 
virus replication rate. As the cell population decreases, cells that carry Ig proteins 
strongly binding to viruses acquire selective advantage, as their replication rate is higher, 
while virus replication within such cells is hindered. Accordingly, the population-
averaged thermal probability of interaction between Ig and virus proteins Pint (see 
Methods) sharply increases from a value of 0.25, characteristic for two random proteins 
under the simulation conditions, to about 0.7, see Figure 1C. This result points to the 
emergence of a strongly binding Ig protein as a result of population-level selection of 
most immune cells in the presence of a mutating virus and Immunoglobulin genes. 
 Figure 1D represents a phase diagram of the model, where the color corresponds 
to the probability of cell survival at the given mutation rates of virus mv and of Ig protein 
mIg. The letters H, C, and E designate typical outcomes of the infections (healing, chronic 
infection, or host extinction) in the corresponding areas of the diagram. For a given 
combination of mutation rates, the outcome of an individual simulation run (representing 
an individual infection event) depends on the stochastic events leading to discovery or 
non-discovery of strongly binding Ig proteins and changes in stabilities of functional 
proteins (apoptotic pathway, see below). In many cases, the healing or extinction runs 
bear a significant similarity, and are different from the chronic infection pathway: healing 
and extinction pathways proceed through a narrow population bottleneck, whereas the 
population decrease in the chronic infection case is less drastic. Indeed, once the 
population had been sufficiently reduced, number fluctuations of both cells and viruses 
become significant, and may lead to the extinction of either viruses (in the healing case), 
or cells and viruses together in the extinction, or lethal infection case. 
 The microscopic modeling of interactions between cell and virus proteins in our 
model permits a detailed investigation of the emergence of immunity. The most direct 
path - hindering virus replication by evolving a strongly binding Ig protein - has been 
presented in Figure 1C. A more careful examination shows that the model cells also 
develop apoptosis as a complementary way of fighting the infection. Experimentally, 
apoptosis was found in naïve vertebrate hosts (20-22) as a first line mechanism of host 
defense. Plants, instead of recruiting B-, T-cells, and macrophages to eliminate the 
pathogens, activate the apoptotic pathway in the infected cells, in hope to eliminate the 
virus by killing its host cells thus stopping further virus production. Similarly, certain 
bacteria can induce premature activation of the lytic pathway of the infecting phage 
before virus assembly is complete, preventing the release of assembled viruses into the 
community (abortive phage resistance,(23, 24)). Interestingly, such a collective defense 
mechanism emerges naturally in our model. Indeed, in the model the cell lifetime is 
determined by the stability of the functional, non-Ig proteins. As seen in Figure 2B, after 
the infection, the life time of the cells decreases.  
 
 
 
Figure 2. 
The anatomy 
of a healing 
event. (A) 
Total 
population of 
cells, 
population of 
infected cells 
and viruses in 
a simulation 
run resulting 
in healing. (B) After the acute infection is over, average cell lifetime decreases through 
selection of cells with somewhat lower stability of their normal proteins, pointing to the 
emergence of apoptotic defense mechanism. The black line represents the average time 
between cell division events reflecting the effects of virus infection and subsequent 
activation. 
 
The apoptosis-like decrease of cell lifetimes is favorable for fighting infection, as viruses 
may not have enough time to reach the lysis threshold, if the cell terminates itself 
prematurely. In this way, viruses are removed from the population together with their 
host cells. After the infection had subsided, the life time of the cells gradually returns to 
pre-infection levels (Figure 2B). By comparing Figures 1C and 2B, we conclude that in 
the model, the rapid response to the infection is evolution of strongly binding Ig 
sequences, while the decrease of cell lifetime via lowered stability of non-Ig proteins 
occurs at longer times when the acute phase is over. Interestingly, CD4+ T cell apoptosis 
has been found as one of the responses to HIV infection (2, 3). 
 Selection of specific, strongly binding Ig proteins from a vast pool of initial 
prototypical B-cells carrying a very large set of un-optimized Ig sequences proceeds in 
our model via clonal selection with subsequent affinity maturation. In Figure 3A we 
present the histogram of the Ig-to-virus binding strength Pint distributions at four time 
slices. Immediately after infection, t=2001 (black curve), most of the Ig sequences exhibit 
a marginal binding to the viral antigen with Pint~0.25, typical for two random proteins in 
this model. However, a small fraction of B-cells carries Ig molecules with a relatively 
strong binding, Pint>0.4 (tail of the distribution, shaded area). Subsequently, such cells 
enjoy selective advantage (see Eq. (2)), and their fraction in the population increases 
(t=2020, red curve). This is similar to the natural clonal selection process.(17) 
Furthermore, as the (moderately) binding sequences have been discovered, they undergo 
mutations with further selection, corresponding to affinity maturation increasing the 
binding strength Pint to its final value of ~0.7 (t>2050, green and blue curves),. To 
confirm that the strongly binding Ig’s are normally direct descendants of the original 
moderately binding sequences selected at the first – clonal selection – stage of the 
immune response, we marked cells with Pint>0.4 as ‘’red’’ when infection first occurred 
and their ancestors have never been infected, and postulated that their progeny retains the 
‘’red’’ color. In Figure 3B, we plotted the fraction of the ‘’red’’ cells in the population. 
One can see that the fraction of the ‘’red’’ cells initially increases with time, and reaches 
its maximum as the cells recover from the infection (cf. Figure 1). Therefore, virus 
removal is mostly accomplished by the direct descendants of the few Ig sequences that 
accidentally had a certain binding affinity and have been amplified and optimized via a 
two-stage process of clonal selection and affinity maturation. Our simulations suggest 
that the primary role of clonal selection is to amplify B-cells with moderately binding 
sequences from a diverse pool that evolved before the antigen was presented.  As a next 
step, cells carrying clonally selected Ig genes undergo improvement by specific mutations 
dramatically increasing the binding strength. Evidently, such mutations can be efficiently 
discovered only during mutagenesis in a pool of moderate binders, rather than by pure 
chance among pseudorandom sequences. Importantly the fraction of progenitors of 
clonally selected ‘’red’’ cells drops after infection is eliminated but it returns to the level 
which is higher than initial one (see long-time plateau in Fig.3B) reflecting effect of 
memory. Indeed, upon re-infection the cells exhibit memory effect in their immune 
response (data not shown). 
 Next, we study the distribution of sequences of evolving Ig proteins. In Figure 3C, 
we present the measure of sequence diversity - sequence entropy - of evolved Ig 
sequences (black curve) and Ig-to-virus binding strength Pint (red curve) as function of 
time. The figure shows that discovery of strongly binding Ig proteins, manifested in a 
sharp increase in Pint , is accompanied by a drop in the sequence entropy of Ig proteins. 
As the infection is being eliminated, the Ig proteins have the minimum sequence entropy 
and are essentially monoclonal, similar to the production of large quantities of specific, 
monoclonal B-cells in vertebrate immune systems upon infection.  
 
Figure 3. 
Clonal selection and affinity maturation. (A) Histogram of the binding strength Pint  in 
the ensemble of Ig molecules at various times. From t=2001 to t=2020, clonal selection 
increases the fraction of Ig’s strongly binding the virus: the tail of the distribution 
becomes more prominent, while the maximum is unmoved. As time goes on, mutations in 
the previously selected Ig genes further increase Pint and shift the distribution to the right 
until monoclonal population of strongly binding Ig molecules emerges. (B) We marked 
the cells with Pint>0.4 at t=2001 (shaded area in (A)) as ‘’red’’ and followed the fraction 
of their progeny. As the infection is being removed, most of the Ig’s are descendants of 
the few strongly binding sequences amplified via clonal selection. (C) Sequence entropy 
of the evolving Ig proteins (black line) and their binding strength Pint as function of time 
(ref). Development of immunity is accompanied by a rapid increase of Pint and a decrease 
of the sequence entropy of Ig proteins, confirming the appearance of a monoclonal Ig 
population in response to infection. 
 
        The two-stage process of discovery of potent Ig proteins explains existence of 
optimal rate of somatic hypermutation for Ig genes at which immune response is most 
efficient (see Fig.1D). Qualitatively, this is due to the fact that affinity maturation occurs 
in population of already pre-selected (via clonal selection) cells carrying moderately 
potent Ig proteins. In this case too low mutation rate of Ig  proteins will prevent affinity 
maturation while too high mutation rate could result in predominantly deleterious 
mutations which destroy even moderate binding of Ig to antigens developed at the clonal 
selection stage. A more quantitative analysis provided in Supplementary Text suggests 
that optimal mutation rate per amino acid in Ig  is determined by the relation: 
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where t is  a characteristic time of affinity maturation (which may depend on replication 
rate of the virus), 0G∆  is average change of binding free energy per amino acid upon 
mutation in the population of clonally selected Ig proteins, and σ  is standard deviation of 
this quantity in a statistical pool of mutations. The result given by Eq.3 clearly highlights 
the role of clonal selection in determining the optimal Ig mutation rate. Indeed in the 
ensemble of Ig molecules that had been initially selected for antigen binding, random 
mutations have in average a detrimental effect on binding energy. Hence, the value of 
0G∆  , the energetic effect of a random mutation on the antigen affinity of binding Ig 
molecules will be significant. Stronger clonal selection at the first stage leads to increase 
of 0G∆ , and  the optimal rate approaches its absolute limit of just one mutation per 
variable part of Ig in affinity maturation process. Alternatively, in unselected naïve 
population, 0 0G∆ = , which means that a mutation has equal probability to strengthen 
and to weaken binding to the antigen. In this case there is no optimal rate of Ig mutations 
– the faster the better. Interestingly the optimal mutation rate observed in our simulations 
– roughly two amino acid mutations per variable region in affinity maturation process  
(see Supplementary Text and Figure S2) – is very close to the hypermutation rates 
(HMR) observed in Nature (17). Further our theory predicts that optimal HMR does not 
depend on virus mutation rate – in agreement with simulations (see Fig.1D) and estimates 
that show similar HMR for broad range of infections (11, 25, 26).  
 
Conclusions 
We presented a simple, microscopic model of immunity in an interacting host-pathogen 
system. We built the model entirely bottom-up, starting from protein sequences, 
calculating their thermodynamic properties, such as stability and ability to interact  with 
each other, and making simple, well-defined assumptions about the effects of protein 
stability and interactions on the reproductive rates of both cells and viruses. A complex 
interplay between genetics, physics of proteins, and population dynamics provides a rich 
variety of dynamical regimes, identifying all possible outcomes such as healing, host 
extinction, and chronic infection as function of the mutation and replication rates. We 
have demonstrated that these minimal assumptions are sufficient for the discovery of 
monoclonal Ig-like virus-binding proteins in a two-stage process that involves clonal 
selection and affinity maturation, and, more surprisingly, for uncovering the apoptotic 
pathway as a means of collective defense against the infection. Microscopic consideration 
of the sequences allowed a clear dissection of the clonal selection and affinity maturation 
mechanisms, which allow for fast and efficient selection of specific, strongly binding Ig 
sequences from an initial pool of randomized, non-specific Immunoglobulins. We have 
shown that B-cell activation followed by fast clonal selection is indispensable for 
overcoming the infection, as a direct discovery of Ig sequences from a random pool is 
prohibitively inefficient and persistently leads to chronic infection. The presented 
diagram of the infection outcomes as function of the mutation rates can be of interest for 
the development of therapeutic approaches to certain diseases. 
          Our model reproduces qualitatively all phases of the dynamics of HIV infection – 
acute first viremia, initial rapid clearance due to emerging immune response, nadir, latent 
phase and final viremia at the onset of AIDS (see blue chronic infection curve on Fig.1B). 
            A population dynamics view on immunity emphasizes competition between host 
and pathogen (9). The present microscopic model, while confirming this aspect of 
immune response, points out to an important aspect of immunity which is independent on 
dynamics of viral mutational load. Indeed, two-stage process of selection of  potent  
Immunoglobulins requires mutation dynamics that is to a large extent independent on the 
mutation rates of  viruses – as can be seen on the phase diagram Fig.1D which shows that 
no healing can occur when mutation rate of Immunoglobulins is too low, regardless of 
viral mutation rate. However, necessary maturation time (and therefore optimal SHM rate 
in Eq.(3)) may depend on dynamics of viral replication.  This finding points out to the 
necessary and universal character of SHM. 
           An important aspect of our microscopic model is autoimminity which significantly 
restricts sequence evolution of Immunoglobulins. Deem and coworkers suggested that 
cross-reactivity may affect the affinity maturation dynamics (27). Further analysis of our 
model can shed more light on the interplay between autoimmunity and dynamics of 
sequence selection of potent Immunoglobulins.  
           One important observation in our model is that healing may occur only via a 
crucial population bottleneck when the number of cells drops dramatically. Such scenario 
is perhaps not realistic for immune infections, like HIV (where T-cell count is essential 
for organism’s survival) and Epstein-Barr virus (infecting B-cells). Therefore most likely 
outcome of an infection targeting immune system is a chronic pathway and vaccination 
may be not efficient to fight this outcome. However, therapies that provide additional 
elimination of viruses by lowering their replication rates may help to avoid the bottleneck 
scenario and result in clearance of viral titer in the population. 
          Our model is still quite minimalistic as it uncovers general robust features of 
immune response on various scales while exact molecular mechanisms here are quite 
schematic and differ significantly from actual biological pathways that operate in living 
cells. Nevertheless the striking similarity of the mechanism of adaptive immunity which 
are found here to those discovered in jawed vertebrates attests to the robustness and 
certain degree of inevitability of evolutionary processes that lead to adaptive immunity. It 
is quite remarkable to observe the anatomy of evolutionary events - how complex 
biological functions and responses emerge as a result of mutation and natural selection 
processes as postulated by Darwin long ago. 
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Supplementary Text 
 
Methods 
 
Protein model: Stability and interactions 
 
 We consider a 3x3x3 lattice protein as a model protein in order to calculate 
thermodynamic quantities such as protein stability and protein interaction strength 
exactly (1, 2). To save computer time, we reduce protein structural space from 103,346 
structures to randomly and uniformly chosen 10,000 structures. Each protein folds into 
the native structure which has minimum energy out of 10,000 structures. Protein stability 
is calculated in terms of the Boltzmann probability (Pnat) of the native structure of the 
protein at given temperature, 
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where g is a protein sequence, E0(g) and Ei(g) are energies of protein in the native and i-
th structure respectively, and T is an environmental temperature. In order to calculate 
interaction strength between two proteins, we consider rigid-body docking between two 
3x3x3 lattice proteins. Each lattice protein has six binding surfaces and four-fold 
rotational symmetry of a binding surface (only the strongest binding positions sharing 9 
interaction bonds are taken into account). Therefore, a pair of lattice proteins has 6x6x4 
binding conformations. Protein interaction strength is defined by the Boltzmann 
probability (Pint) of the native binding between two protein g1 and g2 as following. 
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where E0(g1, g2) is the minimum binding energy of two proteins out of 144 binding 
modes, and f is a pre-factor that takes into account possible different strengths of intra-
protein and inter-protein interactions. We use the Miyazawa-Jernigan pairwise contact 
potential for both protein structural and interaction energies (3), but scale protein-protein 
interactions by a constant factor. We chose T = 0.85 in Miyazawa-Jernigan dimensionless 
energy unit and f = 1.2. 
 
Cell dynamics; reproduction, death, immunity, and autoimmunity 
 
We develop a simple model cell whose life is described by genetic information 
encoded in its genome. The genome of a cell consists of four genes. The first gene, 
named Ig (immunoglobulin-like) gene, is assigned for the function of immunity, and the 
remaining three genes are normal functional genes which control the life of the cell. In 
the model, Ig protein’s interaction strength is responsible for the molecular recognition 
and suppression of extrinsic proteins. Once a cell is infected by a virus, it can obtain 
immunity against the virus by increasing the Ig protein’s interaction strength to viral 
RNA or enzymes. Also, the Ig protein should recognize “self” genes from “non-self” 
genes. If it mistakes “self” proteins for “non-self” proteins and binds them strongly, it 
suppresses the function of cellular proteins. This is the main cause of autoimmunity and it 
is incorporated into the reduction of cell division rate b which describes as follows 
 
 [ ]),(max1 int0 ii gIgPbb −⋅= , (S3) 
 
where b0 is a cell division rate constant and Pint(Ig,gi) is the interaction strength between 
Ig and i-th normal functional protein in the cell and index i runs from 1 to 3. A loss of a 
functional protein’s stability results in malfunction of life controlling system of the cell 
(1). We connect the minimum stability of any functional protein in a cell to death rate d 
of the cell as following. 
 
 [ ])(min10 inati gPdd −= , (S4) 
 
where d0 is a cell death rate constant and Pnat(gi) is gi protein’s stability and index i runs 
from 1 to 3. As the population grows, cells with lower death rate to spread out their 
offspring due to longevity. This selection pressure enriches the system with extremely 
stable functional protein as a majority. In order to avoid the system being driven to the 
extreme, we introduce the concept of marginal stability in the model. The upper limit of 
P*nat is set in the model and Pnat value is substituted with the upper limit when it exceeds 
the upper limit, so the there is no pressure towards evolving proteins with native state 
stability above P*nat . 
 
 
Virus dynamics; replication and lysis 
 
 A viral particle carries a single protein (antigen), denoted by v. A free viral 
particle can infect a cell which is unoccupied by other viral particles with viral infection 
rate. This particle can be mutated or replicated only when it resides in an infected host 
cell. When the population of the viral particles in a living host cell exceeds the lysis 
threshold, the viral particles bring about lysis in the cell and are released. If free viral 
particles cannot find an unoccupied (uninfected) host cell, they are removed. The 
replication rate of virus is regulated by its protein stability and protein interaction strength 
with Ig protein. A viral replication rate bv can be written as following. 
 
 ( )),(1)( int0 vIgPvPbb natvv −⋅⋅= , (S5) 
 
where b0v is a viral replication rate constant, Pnat(v) is protein stability of virus, and 
Pint(Ig,v) is protein interaction strength between Ig and viral protein. Once a virus infects 
a cell, it takes over the resources of the cells and reduces the resources available for cell 
reproduction. Therefore, the reproduction rate of infected cell is also regulated by Ig 
protein’s interaction strength with viral protein. Viral infection modifies cell reproduction 
rate as follows: 
 
 [ ] ),(min),(max1 intint0 jjii vIgPgIgPbb ⋅−⋅= , (S6) 
where Pint(Ig,vj) is Ig protein’s interaction strength with j-th viral particle in the cell, and 
index j runs 1 to the number of viruses in the cell. 
 
Simulations 
 
 Initially 100 cells are seeded with 4 identical primordial genes. Initial simulation 
runs with cell reproduction rate constant, b0 = 0.339 and cell death rate constant, d0 = 
0.145. Due to the differences between the time scales of protein evolution and a much 
faster response to a viral infection, the population dynamic simulation proceeds in two 
steps. For 1500 initial time steps, cells are allowed to evolve with mutation rate of 
functional proteins in the cell, m=0.005 (attempted mutations per gene per unit time) in 
order to equilibrate the system. Then, the attempted mutation rate is reduced to m=0.0005 
and the cells evolve for 500 time steps to re-equilibrate system at the new mutation rate. 
At t=2001, 1000 identical free viruses are introduced in the system, starting the infection 
with the viral infection rate, 0.75. The sequence of viral protein is randomly chosen 
before simulation, whose initial stability, Pnat=0.5. The upper limit of Pnat for functional 
and viral protein is set to 0.5. The viral replication rate constant b0v and the lysis threshold 
are set to 2.27 and 4. After infection, the system evolves up to t=4000. 
 
Sequence entropy calculation 
 
In order to observe selection of monoclonal Ig proteins, we calculated the 
sequence entropy of Ig proteins. The sequence entropy of a residue in k-position is 
defined as following (4). 
 ki
i
k
ik PPS ∑
=
−=
20
1
log  (S7) 
,where Pik is a probability to find i-type amino acid in k-position. The sequence entropy is 
then averaged for all 27 positions in a sequence. 
 
The importance of cell activation by antigen – cell reproduction rate dependence on 
Ig-virus interaction strength. 
 
Viral infection interferes with cellular functions related to cell cycle(5) and, most 
importantly recognition of antigen of B cells stimulates their proliferation. In our model, 
we incorporate this effect into Eq. (6). In order to study the importance of the relation 
between viral infection and cell reproduction rate, we ran control simulations where we 
neglected the dependence on Ig-virus interaction strength, Pint(Ig,v), i.e. for this control 
simulation we  modified the Eq (6) as follows: 
 
 [ ]),(max1 int0 ii gIgPbb −⋅= , (S8) 
 
We ran 200 control simulations with modified cell reproduction rate dependence Eq.(S8). 
No healing or death outcomes were observed, because viral infection without interfering 
cell cycle does no harm to cells. Population of cells still keeps growing in Figure S1A and 
S1D. Population of viruses exhibits exponential growth up to t=2055, then fluctuates 
around 9,000 because there exists no uninfected cell any more (Figure S1B). In Figure 
S1C, Pint(Ig,v) cannot reach as the high level as in original simulation, because no 
decrease of cell population weakens evolutional pressure to select cells with higher 
immunity. Reproduction of cells in control simulations is not affected by viral infection 
(Figure S1D), and no apoptosis is induced. 
 
 
Derivation of the optimal Ig mutation rate 
 
Consider affinity maturation time scale t. At this time scale N mutations can occur and we 
are interested in the probability that affinity will be improved. Since we mutate Ig’s 
which represent a biased (towards stronger binding) ensemble that was are already pre-
selected (via clonal selection), then a mutation is statistically more likely to be 
destabilizing. Assume Gaussian probability density distribution for the mutation effect on 
binding free energy (6): 
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Here 0G∆  represents the average effect of each mutation. 0 0G∆ >  means that mutations 
statistically tend to be destabilizing; this is the case for the preselected ensemble of Ig 
molecules biased towards stronger binding to an antigen. σ  is standard deviation of the 
energetic effect of single mutations. The effect of N mutations occurring in a replication 
cycle is additive, hence probability density should scale according to Central Limit 
Theorem (assuming that the mutations are uncorrelated and independent): 
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The probability that N mutations occur in the given time frame t follows the Poisson 
distribution: 
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where m is amino acid mutation rate per variable Ig domain.  The probability that 
mutations improve binding, i.e. that affinity maturation could occur,  is: 
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where we used the change of variables: 
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The last integral is error function which can be asymptotically approximated as  
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which is the Eq.(3) of the main text. 
 
Comparison of the optimal model Ig mutation rates with experiment. 
 
The attempted mutation rate of the ‘’normal genes’’ in the model is 45 10normalm
−= ⋅  per 
time step per gene. The optimal attempted mutation rate for Ig-genes is roughly 10 times 
greater (see Fig.1C), i.e. it is 35 10optIgm
−= ⋅  per gene per time step. However, importantly, 
the actual rate at which amino acid mutations accrue in the population of Ig genes is 
higher – it is about 22 10−⋅  per time step per gene (see Fig.S2). The difference is due to 
the fact that Ig genes are under selection and populations get enriched with Ig’s that 
accumulated favorable mutations. Similar effects contribute to the overall estimate of the 
SHM rates in real B-cells (7). The estimated SHM rates is 310−  per bp per generation (7, 
8) which translates roughly into 0.3 mutations per variable Ig gene (110 amino acids) per 
generation. In our simulations cells divide roughly once in 10 time steps, i.e. in our case 
we effectively observe 0.2 mutations per Ig gene per generation at optimal Ig mutation 
attempt rate. This is close to the experimental value of 0.3, and the difference may be due 
to different relative sizes of antigen recognition sites in our small model proteins and in 
larger real Immunoglobulins (apart from the fact that in real variable parts of Ig genes 
mutation rates may be higher  in hot spots such as CDRs (8, 9) . Further, in our case full 
affinity maturation occurs in 100 time steps – roughly 10 generations ( see Fig. 3A) 
which is again close to real situation (7). 
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Supplementary Figures 
 
 
Figure S1. 
 
Control simulation without cell activation by antigen i.e. without cell replication rate 
dependence on Pint(Ig,v) (red curves). For comparison purposes we also provide here 
the results from the healing pathway in the original simulations where cell activation is 
included (black curves) (A) Population of cells does not decrease without cell activation. 
(B) Population of viruses saturated around 9,000 and no healing occurs in control 
simulations. (C) No selection for strongly binding Immunoglobulins: Ig-virus interaction 
strength in control simulation is significantly lower than one in original simulation. (D) 
The solid and dotted lines, respectively, represent averaged cell division time (1/b) and 
lifetime (1/d) as function of simulation time. No dramatic change in cell division time and 
no apoptosis is observed in control simulation. 
 
  
Figure S2.  
Average accumulated mutation counts of normal functional and Ig gene of cells. The 
black and red lines respectively show the averaged effective mutation counts of normal 
and Ig gene which are accumulated in the genome of survived cells during simulation. 
This quantity is calculated by tracing ancestry of each gene to the original progenitor 
gene and averaging over all exiting genes in the population at each time point. Note that 
this quantity is different from attempted mutation rates due to effect of selection on both 
‘’normal genes’’ of the cell and Immunoglobulin genes.  Before t=1501, we observed 
different accumulation mutation rates of 0.0153 and 0.0179 (mutations per gene per unit 
time) for normal genes and Ig genes (reflecting higher selection pressure on Ig due to 
autoimmunity constraint), even though we apply the same attempted mutation rate, 0.005 
to both genes. At t=1501 the attempted mutation rate drops ten-fold for both normal and 
Ig genes. Infection occurs at t=2001 at which time attempted mutation rate for Ig genes 
increases in Igm  times (10 in this example corresponding to optimal mutation rates for Ig 
in Fig 1D). High positive selection pressure is exerted on Ig gene after infection resulting 
in higher rate of accumulated mutations ( 22 10−⋅ ) than the rate of attempted Ig mutations 
( 35 10−⋅ ). After virus infection at t=2001, normal genes accumulate some mutations in 
order to induce apoptosis and then dissipate the accumulated mutations after healing. 
This results in apparent negative slope of the curve for normal genes (black) which 
reflects population effect of post-healing survival of cells that accumulated smaller 
number of mutations and had more stable proteins. 
 
 
 
  
 
 
 
  
 
 
  
 
  
 
 
 
